1. Husereau D, Arshoff L, Bhimani S, N. A. Medical device and diagnostic pricing and reimbursement in Canada. Institute of Health Economics 2015. Report No.: 978-1-926929-63-7 Contract No.: 23 May 2018.
2. Government of Canada. Health Canada. Drug and medical device approval overview.
https://www.canada.ca/en/services/health/drug-health-products/drug-medical-device-highlights-2017/approval-overview.html
Accessed 20 Nov 2018.
3. Chittester B. Medical device clinical trials—how do they compare with drug trials? 2014.
https://www.mastercontrol.com/gxp-lifeline/medical-device-clinical-trials-how-do-they-compare-with-drug-trials
. Accessed May 23, 2018.
4. The Clinical Trial Company Group. The challenges in medical device clinical trials.
https://www.tctcgroup.com/single-post/2018/01/23/The-challenges-in-medical-device-clinical-trials
. Accessed 25 May 2018.
5. Fearon WF, Bornschein B, Tonino PA, Gothe RM, Bruyne BD, Pijls NH, et al. Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Circulation. 2010;122(24):2545–50.